Molina Healthcare Appoints New Chief Medical Officer

Ticker: MOH · Form: 8-K · Filed: Aug 20, 2024 · CIK: 1179929

Molina Healthcare, Inc. 8-K Filing Summary
FieldDetail
CompanyMolina Healthcare, Inc. (MOH)
Form Type8-K
Filed DateAug 20, 2024
Risk Levellow
Pages3
Reading Time3 min
Key Dollar Amounts$0.001
Sentimentneutral

Sentiment: neutral

Topics: executive-appointment, compensation, healthcare

Related Tickers: MOH

TL;DR

Molina Healthcare names new CMO, Martha McGinness, with $525K salary + $1M stock.

AI Summary

Molina Healthcare, Inc. announced on August 19, 2024, the appointment of Dr. Martha W. McGinness as Chief Medical Officer, effective August 20, 2024. Dr. McGinness will receive an annual base salary of $525,000 and will be eligible for the company's annual incentive plan. She will also receive a restricted stock unit award valued at $1,000,000, vesting over three years.

Why It Matters

The appointment of a new Chief Medical Officer is a key leadership change that could impact the company's strategic direction in healthcare services and patient care.

Risk Assessment

Risk Level: low — This filing primarily concerns an executive appointment and compensation, which typically carries a low inherent risk.

Key Numbers

  • $525,000 — Annual Base Salary (For new Chief Medical Officer, Dr. Martha W. McGinness.)
  • $1,000,000 — Restricted Stock Unit Award Value (Awarded to Dr. Martha W. McGinness, vesting over three years.)

Key Players & Entities

  • Molina Healthcare, Inc. (company) — Registrant
  • Dr. Martha W. McGinness (person) — Appointed Chief Medical Officer
  • $525,000 (dollar_amount) — Annual base salary for Dr. McGinness
  • $1,000,000 (dollar_amount) — Value of restricted stock unit award for Dr. McGinness
  • August 20, 2024 (date) — Effective date of appointment
  • August 19, 2024 (date) — Date of earliest event reported

FAQ

Who has been appointed as the new Chief Medical Officer at Molina Healthcare?

Dr. Martha W. McGinness has been appointed as the new Chief Medical Officer.

What is the effective date of Dr. McGinness's appointment?

The appointment is effective August 20, 2024.

What is Dr. McGinness's annual base salary?

Dr. McGinness's annual base salary is $525,000.

What is the value of the restricted stock unit award granted to Dr. McGinness?

The restricted stock unit award is valued at $1,000,000.

Over what period will Dr. McGinness's stock award vest?

The restricted stock unit award will vest over three years.

Filing Stats: 787 words · 3 min read · ~3 pages · Grade level 10.9 · Accepted 2024-08-20 09:05:18

Key Financial Figures

  • $0.001 — ge on which registered Common Stock , $0.001 Par Value MOH New York Stock Exchang

Filing Documents

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) Exhibits: Exhibit No. Description 10.1 Amendment to the Employment Agreement, dated as of August 19, 2024. 10.2 Performance Stock Unit Agreement, dated as of August 19, 2024. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. MOLINA HEALTHCARE, INC. Date: August 20, 2024 By: /s/ Jeff D. Barlow Jeff D. Barlow Chief Legal Officer and Secretary

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.